Universidade de São Paulo, Hospital das Clínicas, Departamento de Medicina, Divisão de Nefrologia, São Paulo, SP, Brasil.
Universidade Nove de Julho, São Paulo, SP, Brasil.
J Bras Nefrol. 2021 Oct-Dec;43(4):539-550. doi: 10.1590/2175-8239-JBN-2020-0098.
Patients on hemodialysis are exposed to calcium via the dialysate at least three times a week. Changes in serum calcium vary according to calcium mass transfer during dialysis, which is dependent on the gradient between serum and dialysate calcium concentration (d[Ca]) and the skeleton turnover status that alters the ability of bone to incorporate calcium. Although underappreciated, the d[Ca] can potentially cause positive calcium balance that leads to systemic organ damage, including associations with mortality, myocardial dysfunction, hemodynamic tolerability, vascular calcification, and arrhythmias. The pathophysiology of these adverse effects includes serum calcium changes, parathyroid hormone suppression, and vascular calcification through indirect and direct effects. Some organs are more susceptible to alterations in calcium homeostasis. In this review, we discuss the existing data and potential mechanisms linking the d[Ca] to calcium balance with consequent dysfunction of the skeleton, myocardium, and arteries.
血液透析患者每周至少通过透析液三次暴露于钙。血清钙的变化取决于透析过程中钙质量转移,这取决于血清和透析液钙浓度(d[Ca])之间的梯度以及改变骨摄取钙能力的骨骼周转率状态。尽管未被充分认识,但 d[Ca] 可能导致正钙平衡,从而导致全身器官损伤,包括与死亡率、心肌功能障碍、血流动力学耐受性、血管钙化和心律失常相关的损伤。这些不良反应的病理生理学包括通过间接和直接作用引起的血清钙变化、甲状旁腺激素抑制和血管钙化。一些器官更容易受到钙稳态变化的影响。在这篇综述中,我们讨论了现有的数据和潜在的机制,将 d[Ca] 与钙平衡与骨骼、心肌和动脉功能障碍联系起来。